156 related articles for article (PubMed ID: 11902838)
1. X-ray crystallographic studies of serotonin N-acetyltransferase catalysis and inhibition.
Wolf E; De Angelis J; Khalil EM; Cole PA; Burley SK
J Mol Biol; 2002 Mar; 317(2):215-24. PubMed ID: 11902838
[TBL] [Abstract][Full Text] [Related]
2. Novel bisubstrate analog inhibitors of serotonin N-acetyltransferase: the importance of being neutral.
Zheng W; Cole PA
Bioorg Chem; 2003 Oct; 31(5):398-411. PubMed ID: 12941292
[TBL] [Abstract][Full Text] [Related]
3. Investigation of the roles of catalytic residues in serotonin N-acetyltransferase.
Scheibner KA; De Angelis J; Burley SK; Cole PA
J Biol Chem; 2002 May; 277(20):18118-26. PubMed ID: 11884405
[TBL] [Abstract][Full Text] [Related]
4. Probing the mechanism of hamster arylamine N-acetyltransferase 2 acetylation by active site modification, site-directed mutagenesis, and pre-steady state and steady state kinetic studies.
Wang H; Vath GM; Gleason KJ; Hanna PE; Wagner CR
Biochemistry; 2004 Jun; 43(25):8234-46. PubMed ID: 15209520
[TBL] [Abstract][Full Text] [Related]
5. Structure of arylamine N-acetyltransferase reveals a catalytic triad.
Sinclair JC; Sandy J; Delgoda R; Sim E; Noble ME
Nat Struct Biol; 2000 Jul; 7(7):560-4. PubMed ID: 10876241
[TBL] [Abstract][Full Text] [Related]
6. Divergence of cofactor recognition across evolution: coenzyme A binding in a prokaryotic arylamine N-acetyltransferase.
Fullam E; Westwood IM; Anderton MC; Lowe ED; Sim E; Noble ME
J Mol Biol; 2008 Jan; 375(1):178-91. PubMed ID: 18005984
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic studies on the alkyltransferase activity of serotonin N-acetyltransferase.
Zheng W; Scheibner KA; Ho AK; Cole PA
Chem Biol; 2001 Apr; 8(4):379-89. PubMed ID: 11325593
[TBL] [Abstract][Full Text] [Related]
8. Catalytic mechanism of hamster arylamine N-acetyltransferase 2.
Wang H; Liu L; Hanna PE; Wagner CR
Biochemistry; 2005 Aug; 44(33):11295-306. PubMed ID: 16101314
[TBL] [Abstract][Full Text] [Related]
9. De novo discovery of serotonin N-acetyltransferase inhibitors.
Szewczuk LM; Saldanha SA; Ganguly S; Bowers EM; Javoroncov M; Karanam B; Culhane JC; Holbert MA; Klein DC; Abagyan R; Cole PA
J Med Chem; 2007 Nov; 50(22):5330-8. PubMed ID: 17924613
[TBL] [Abstract][Full Text] [Related]
10. The structural basis of ordered substrate binding by serotonin N-acetyltransferase: enzyme complex at 1.8 A resolution with a bisubstrate analog.
Hickman AB; Namboodiri MA; Klein DC; Dyda F
Cell; 1999 Apr; 97(3):361-9. PubMed ID: 10319816
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and in vitro evaluation of novel derivatives as serotonin N-acetyltransferase inhibitors.
Beaurain N; Mésangeau C; Chavatte P; Ferry G; Audinot V; Boutin JA; Delagrange P; Bennejean C; Yous S
J Enzyme Inhib Med Chem; 2002 Dec; 17(6):409-14. PubMed ID: 12683677
[TBL] [Abstract][Full Text] [Related]
12. Crystallographic and computational studies on 4-phenyl-N-(beta-D-glucopyranosyl)-1H-1,2,3-triazole-1-acetamide, an inhibitor of glycogen phosphorylase: comparison with alpha-D-glucose, N-acetyl-beta-D-glucopyranosylamine and N-benzoyl-N'-beta-D-glucopyranosyl urea binding.
Alexacou KM; Hayes JM; Tiraidis C; Zographos SE; Leonidas DD; Chrysina ED; Archontis G; Oikonomakos NG; Paul JV; Varghese B; Loganathan D
Proteins; 2008 May; 71(3):1307-23. PubMed ID: 18041758
[TBL] [Abstract][Full Text] [Related]
13. The structure of arylamine N-acetyltransferase from Mycobacterium smegmatis--an enzyme which inactivates the anti-tubercular drug, isoniazid.
Sandy J; Mushtaq A; Kawamura A; Sinclair J; Sim E; Noble M
J Mol Biol; 2002 May; 318(4):1071-83. PubMed ID: 12054803
[TBL] [Abstract][Full Text] [Related]
14. Insight into cofactor recognition in arylamine N-acetyltransferase enzymes: structure of Mesorhizobium loti arylamine N-acetyltransferase in complex with coenzyme A.
Xu X; Li de la Sierra-Gallay I; Kubiak X; Duval R; Chaffotte AF; Dupret JM; Haouz A; Rodrigues-Lima F
Acta Crystallogr D Biol Crystallogr; 2015 Feb; 71(Pt 2):266-73. PubMed ID: 25664736
[TBL] [Abstract][Full Text] [Related]
15. The conserved glycine/alanine residue of the active-site loop containing the putative acetylCoA-binding motif is essential for the overall structural integrity of Mesorhizobium loti arylamine N-acetyltransferase 1.
Atmane N; Dairou J; Flatters D; Martins M; Pluvinage B; Derreumaux P; Dupret JM; Rodrigues-Lima F
Biochem Biophys Res Commun; 2007 Sep; 361(1):256-62. PubMed ID: 17658468
[TBL] [Abstract][Full Text] [Related]
16. Evidence that WbpD is an N-acetyltransferase belonging to the hexapeptide acyltransferase superfamily and an important protein for O-antigen biosynthesis in Pseudomonas aeruginosa PAO1.
Wenzel CQ; Daniels C; Keates RA; Brewer D; Lam JS
Mol Microbiol; 2005 Sep; 57(5):1288-303. PubMed ID: 16102001
[TBL] [Abstract][Full Text] [Related]
17. Melatonin biosynthesis: the structure of serotonin N-acetyltransferase at 2.5 A resolution suggests a catalytic mechanism.
Hickman AB; Klein DC; Dyda F
Mol Cell; 1999 Jan; 3(1):23-32. PubMed ID: 10024876
[TBL] [Abstract][Full Text] [Related]
18. Bisubstrate ketone analogues as serotonin N-acetyltransferase inhibitors.
Kim CM; Cole PA
J Med Chem; 2001 Jul; 44(15):2479-85. PubMed ID: 11448230
[TBL] [Abstract][Full Text] [Related]
19. Receptor- and ligand-based study on novel 2,2'-bithienyl derivatives as non-peptidic AANAT inhibitors.
Lepailleur A; Lemaître S; Feng X; Sopkova-de Oliveira Santos J; Delagrange P; Boutin J; Renard P; Bureau R; Rault S
J Chem Inf Model; 2010 Mar; 50(3):446-60. PubMed ID: 20196559
[TBL] [Abstract][Full Text] [Related]
20. New substrate analogues of human serotonin N-acetyltransferase produce in situ specific and potent inhibitors.
Ferry G; Ubeaud C; Mozo J; Péan C; Hennig P; Rodriguez M; Scoul C; Bonnaud A; Nosjean O; Galizzi JP; Delagrange P; Renard P; Volland JP; Yous S; Lesieur D; Boutin JA
Eur J Biochem; 2004 Jan; 271(2):418-28. PubMed ID: 14717709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
